Licensees Sought For Osteotech Grafton DBM; Firm Cuts Workforce By 5%
This article was originally published in The Gray Sheet
Executive Summary
Osteotech aims to improve domestic sales of its Grafton demineralized bone matrix business by initiating licensing deals with large orthopedic players